561 related articles for article (PubMed ID: 15731312)
1. Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy.
Palagiano A; Bulletti C; Pace MC; DE Ziegler D; Cicinelli E; Izzo A
Ann N Y Acad Sci; 2004 Dec; 1034():200-10. PubMed ID: 15731312
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction.
Kleinstein J;
Fertil Steril; 2005 Jun; 83(6):1641-9. PubMed ID: 15950631
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support.
Simunic V; Tomic V; Tomic J; Nizic D
Fertil Steril; 2007 Jan; 87(1):83-7. PubMed ID: 17081536
[TBL] [Abstract][Full Text] [Related]
4. Double-blind controlled trial of progesterone substitution in threatened abortion.
Gerhard I; Gwinner B; Eggert-Kruse W; Runnebaum B
Biol Res Pregnancy Perinatol; 1987; 8(1 1ST Half):26-34. PubMed ID: 2437967
[TBL] [Abstract][Full Text] [Related]
5. [Luteal phase support after vaginal progesterone: comparative study with micronized oral progesterone].
Pouly JL; Bassil S; Frydman R; Hédon B; Nicollet B; Prada Y; Antoine JM; Zambrano R; Donnez J
Contracept Fertil Sex; 1997; 25(7-8):596-601. PubMed ID: 9410372
[TBL] [Abstract][Full Text] [Related]
6. Pilot study evaluating a progesterone vaginal ring for luteal-phase replacement in donor oocyte recipients.
Stadtmauer L; Harrison DD; Boyd J; Bocca S; Oehninger S
Fertil Steril; 2009 Nov; 92(5):1600-5. PubMed ID: 18990373
[TBL] [Abstract][Full Text] [Related]
7. Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial.
Tomic V; Tomic J; Klaic DZ; Kasum M; Kuna K
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():49-53. PubMed ID: 25622239
[TBL] [Abstract][Full Text] [Related]
8. Uteroplacental circulation in early pregnancy complicated by threatened abortion supplemented with vaginal micronized progesterone or oral dydrogesterone.
Czajkowski K; Sienko J; Mogilinski M; Bros M; Szczecina R; Czajkowska A
Fertil Steril; 2007 Mar; 87(3):613-8. PubMed ID: 17126337
[TBL] [Abstract][Full Text] [Related]
9. Oral micronized progesterone combined with vaginal progesterone gel for luteal support.
Tomic V; Tomic J; Klaic DZ
Gynecol Endocrinol; 2011 Dec; 27(12):1010-3. PubMed ID: 21504340
[TBL] [Abstract][Full Text] [Related]
10. [Luteal phase support in assisted reproductive cycles using either vaginal (Crinone 8) or intramuscular (Prontogest) progesterone: results of a prospective randomized study].
Anserini P; Costa M; Remorgida V; Sarli R; Guglielminetti E; Ragni N
Minerva Ginecol; 2001 Aug; 53(4):297-301. PubMed ID: 11431647
[TBL] [Abstract][Full Text] [Related]
11. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
Serna J; Cholquevilque JL; Cela V; Martínez-Salazar J; Requena A; Garcia-Velasco JA
Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of the vaginal administration of natural progesterone in patients with recurrent spontaneous hormone caused abortion].
Vignali M; Centinaio G
Minerva Ginecol; 2000 Sep; 52(9):367-74. PubMed ID: 11189968
[TBL] [Abstract][Full Text] [Related]
13. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer.
Mui Lam P; Chun Cheung M; Ping Cheung L; Ingrid Lok H; John Haines C
Gynecol Endocrinol; 2008 Dec; 24(12):674-80. PubMed ID: 19172535
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized trial.
Yanushpolsky E; Hurwitz S; Greenberg L; Racowsky C; Hornstein MD
Fertil Steril; 2008 Feb; 89(2):485-7. PubMed ID: 17572412
[TBL] [Abstract][Full Text] [Related]
15. Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study.
Erdem A; Erdem M; Atmaca S; Guler I
Fertil Steril; 2009 Jun; 91(6):2508-13. PubMed ID: 18692788
[TBL] [Abstract][Full Text] [Related]
16. Progesterone - induced blocking factor (PIBF) and Th(1)/Th(2) cytokine in women with threatened spontaneous abortion.
Hudić I; Fatusić Z
J Perinat Med; 2009; 37(4):338-42. PubMed ID: 19290853
[TBL] [Abstract][Full Text] [Related]
17. Prenatal administration of vaginal progesterone and frequency of uterine contractions in asymptomatic twin pregnancies.
de Oliveira LA; Brizot ML; Liao AW; Bittar RE; Francisco RP; Zugaib M
Acta Obstet Gynecol Scand; 2016 Apr; 95(4):436-43. PubMed ID: 26669629
[TBL] [Abstract][Full Text] [Related]
18. Uterorelaxing effects of vaginal progesterone: comparison of two methodologies for assessing uterine contraction frequency on ultrasound scans.
Ayoubi JM; Fanchin R; Kaddouz D; Frydman R; de Ziegler D
Fertil Steril; 2001 Oct; 76(4):736-40. PubMed ID: 11591407
[TBL] [Abstract][Full Text] [Related]
19. Effect of progesterone treatment due to threatened abortion in early pregnancy for obstetric and perinatal outcomes.
Duan L; Yan D; Zeng W; Yang X; Wei Q
Early Hum Dev; 2010 Jan; 86(1):41-3. PubMed ID: 20079582
[TBL] [Abstract][Full Text] [Related]
20. First trimester threatened miscarriage treatment with human chorionic gonadotrophins: a randomised controlled trial.
Qureshi NS; Edi-Osagie EC; Ogbo V; Ray S; Hopkins RE
BJOG; 2005 Nov; 112(11):1536-41. PubMed ID: 16225575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
